← All Sponsors
SPONSOR

Pasithea Therapeutics Corp.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: RAS MutationNF1 MutationRAF MutationAdvanced Solid Tumors
NCT06299839 Phase 1
Recruiting

PAS-004 in Patients With Advanced Solid Tumors

RAS Mutation
United States, Bulgaria, Romania View Trial →